Shenzhen Capital Group

Shenzhen Capital Group Co., Ltd is a venture capital firm established in 1999 by the Shenzhen Government. The company focuses on fostering national industries, enhancing national brands, and facilitating economic transformation through investments in small to medium enterprises and innovative high-tech companies. It targets businesses in their start-up, growth, and transformation stages, primarily within sectors supported by national policies, including information technology, internet, new media, biopharma, new energy, environmental protection, chemical engineering, and high-end equipment manufacturing. With registered capital of 5.42 billion RMB and total assets under management of 338.99 billion RMB, SCGC has built a substantial portfolio, comprising nearly 1,000 companies, with significant investments totaling 43.9 billion RMB. As of April 2019, the firm was recognized as a leader in the venture capital space, with 145 of its portfolio companies successfully listed across 16 global capital markets.

Fang Aihua

Investment Director

Haitao Jin

Chairman

Suhua Liu

President

Zhou Songgan

Investment Manager

Huang Tianxiang

Investment Director

Xidong Wang

Vice President

Zhang Yuhao

Senior Investment Manager

Lin Yunyu

Investment Director

Ding Zuo

Chairman

Past deals in Nanotechnology

Cytocares

Series A in 2023
Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.

Boston Micro Fabrication

Series C in 2022
BMF Precision is a micro-scale 3D printing system manufacturer dedicated to the development of micro-scale 3D printing systems and functional composites. Used in microfluidics, medical devices, electronics, and education.

Huahuixin Group

Series B in 2022
"Huahuixin" was established in 2017. Its core capabilities are the design, development and production of micro-nano structured optical chips and laser chips, which are in the upstream chip manufacturing link of the optoelectronics industry. There are two main business models: on the one hand, relying on high-end optoelectronic chip technology capabilities to provide joint R&D and foundry services for optoelectronic chip design companies; on the other hand, based on the team's technical capabilities in micro-nano structured optical chips and laser chips, Independent research and development, design and large-scale production of optoelectronic products.

Panchip

Private Equity Round in 2022
Suzhou Panchip Microelectronics Co., Ltd. specializes in the design, development, and marketing of short-distance wireless communication RF chips. Founded in 2010 and based in Suzhou, China, the company also produces low-power real-time clock chips and touch screen controller chips, catering to a variety of applications. Panchip's product offerings include components for wireless mice, wireless audio devices, mobile phone touch screen COF modules, keyboards, remote controls, toys, game keypads, and industrial control systems. Additionally, the company is engaged in developing advanced wireless communication and IoT chips, including a wireless spread spectrum communication platform and high-precision indoor positioning systems, aiming to deliver high-quality, domestically produced solutions for its clients.

NCAP China

Series A in 2022
Huajin Semiconductor is a leading technology developer of semiconductor packaging and testing. Its main technologies include TSV manufacturing, bump manufacturing, TSV exposure, chip stacking, etc. At the same time, it will carry out research and development of various wafer-level high-density packaging processes and SiP product applications. And related equipment research and development, while providing packaging technology services and design simulation services.

H-CHIP TECH

Venture Round in 2022
H-CHIP TECH is a high-end optoelectronic research and development company based in Tianjin, China. It focuses on the development of micro-nano optoelectronic chips for industrial clients, particularly in the realm of distributed feedback (DFB) semiconductors. The company's expertise lies in creating advanced optoelectronic chips that provide reliable technological support for the optical communication industry, catering to the growing demand for innovative solutions in this field.

DERA

Series C in 2021
Developer of storage semiconductors and SSD controllers designed to accelerate applications. The company's storage semiconductors and SSD controllers follow the NVMe standard protocolis, which could reach the performance level of international Tier1 suppliers, enabling enterprises to improve the overall performance of IT facilities.

Zesheng Technology

Series A in 2021
Zesheng Technology is a chemical company mainly engaged in the R&D, production, sales, and technical services of reagent products.

Green Exhibition Technology

Seed Round in 2021
Lvzhan Technology is a high-precision printed electronics solution provider, focusing on the production of functional circuits and electronic devices based on precision printing manufacturing technology. Professionally provide production services for non-silicon-based microelectronic components, sensor chip modules, and high-precision flexible circuits. The company specializes in printed electronic solutions for high-precision functional circuits and electronic devices, in terms of printable nano-metal ink materials, printed electronic packaging materials, high-precision inkjet printing equipment, high-precision inkjet printing processes, and printed electronic circuit design solutions. There is a research and development layout.

Tian An Sensor

Angel Round in 2021
Tian An Sensor is a technology enterprise specializing in optical application sensor system solutions. The company develops photoelectric sensors and applies optical fiber technology, focusing on providing comprehensive sensing technology and sensor devices. Through its innovative software and hardware program services, Tian An Sensor enables businesses to enhance their operational capabilities by utilizing advanced optical sensing solutions.

Leads Biolabs

Series C in 2021
Developer and provider of bio pharmaceutical products designed to create antibodies for the treatment of cancer. The company's research focuses on tumor immunotherapy antibody projects and drugs for cancer treatments, enabling patients to receive tumor and cancer medical treatment and support, improving their conditions.

Ionova Life Science

Venture Round in 2021
Ionova Life Science Co., Ltd. is a biotechnology company based in Shenzhen, China, with additional offices in Hong Kong, Macao, and the Greater Bay Area. Founded in 2016, the company focuses on the discovery and development of novel medicines for cancer treatment, specializing in oncology, immuno-oncology, and tumor-targeted therapies. Ionova employs an in-house built discovery platform to facilitate the development of innovative anti-tumor drugs and immunomodulatory agents. Through its research efforts, the company aims to advance treatments that specifically target tumors and enhance the immune response against cancer.

Bioheng

Series B in 2021
Nanjing Bioheng Biotech Co., Ltd., established in 2017 and based in Nanjing, China, is a clinical biopharmaceutical and biotechnology company that focuses on developing innovative immunotherapies and next-generation gene therapies for cancer and other diseases. The company offers advanced gene editing techniques and CAR-T therapies, and has created a robust production platform for plasmid, virus, and cell manufacturing. Bioheng has developed a GMP-grade clinical translational center and is recognized for its expertise in cell engineering and clinical applications. With a commitment to creating safer and more affordable cell therapy drugs, Bioheng aims to enhance patient access to effective treatments. The company has secured significant funding to further its research and development efforts, leveraging its extensive patent portfolio and industry experience to drive advancements in immunotherapy.

Cryofocus Biotech

Series B in 2021
Cryofocus Biotech is a Shanghai-based cryoablation device manufacturer, focusing on the application of cryogenic technology in the field of cardiovascular interventional therapy.

QureBio

Series A in 2020
QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals. Its goal is to develop new therapeutic drugs for the treatment of refractory cancer, autoimmune diseases, and metabolic diseases in China and the world to benefit patients. QureBio has multiple technology platforms for antibody drug development including phage display technology platforms and hybridoma antibodies technology platform and monoclonal antibody platform. The company was founded in 2017 and is based in Pudong District, Shanghai.

Morion NanoTech

Series A in 2020
Guangdong Morion Nanotechnology Co., Ltd. researches, develops, and manufactures graphene products. The company’s products include graphene lithium battery electrode materials, graphene composite heat sink materials, graphene display touch screen, graphene transistors, graphene powders, graphene film, graphene reinforced rubber, graphene reinforced fiberglass board, and graphene heat conductive film. It also provides testing services. The company was founded in 2015 and is based in Dongguan, China.

Hrain Biotechnology

Series B in 2019
Hrain Biotechnology is a developer of tumor immunotherapy technologies focused on providing targeted treatments for cancer patients. The company specializes in Chimeric Antigen Receptor T-cell (CAR-T) therapy, which leverages biological and cellular technology to deliver precise care. Hrain Biotechnology has established clinical trial platforms and centers in multiple locations, including Beijing, Jiangsu, Chongqing, and Henan, facilitating research and development in innovative cancer treatments. By enabling clinics and hospitals to utilize advanced medical solutions, Hrain Biotechnology aims to enhance patient care and improve treatment outcomes in oncology.

Fanmi Cloud

Series A in 2019
Fanmi Technology Limited, based in Chengdu, China, specializes in the research and development of intelligent maternal and baby health products. With six years of experience in creating professional medical products, the company is dedicated to delivering safe and reliable solutions for infant care. Its product range includes innovative items such as a chip for excreta identification and analysis, an intelligent thermometer for forehead temperature detection, and a toilet test solution. Fanmi Technology aims to leverage advanced technology to enhance the well-being of mothers and their children.

Aluksen

Series A in 2019
Aluksen Technology is an industry leading semiconductor chip manufacturer specializing in optoelectronic technology. The R&D center is located in Silicon Valley, USA. We focus on the telecom, industrial and consumer electronics markets, and gradually form a marketing and service network with Shenzhen as the operation center and covering the global region. We will continue to innovate around customer needs and strive to provide high customers. Quality products and fast, professional technical support and services.

HaploX

Series B in 2018
HaploX Biotechnology Co., LTD. is a Shenzhen-based company founded in 2014 that focuses on developing genomic solutions aimed at personalized medicine. The company specializes in genomics technology designed to enhance the detection of ultra-micro tumor genes. Its innovative approach includes the extraction and parallel amplification of ultra-micro DNA from liquid samples, as well as the precise capture of circulating tumor DNA. HaploX is committed to integrating advanced techniques such as liquid biopsy, genome sequencing, artificial intelligence, and big data to improve cancer diagnosis and treatment.

Frontier Biotechnologies

Series C in 2017
Frontier Biotechnologies Inc. is a commercial-stage biopharmaceutical company based in Nanjing, China, established in 2013. The company specializes in discovering, developing, manufacturing, and commercializing innovative medicines aimed at improving patient health, particularly in the areas of anti-HIV treatment and pain management. Its notable products include Aikening, a long-acting HIV fusion inhibitor, and AB001, a transdermal patch for managing musculoskeletal joint pain. Additionally, Frontier Biotech is developing a combination regimen of Albuvirtide and a monoclonal antibody to combat HIV-1. The company's first product received accelerated approval from the National Medical Product Administration in May 2018, marking a significant milestone in its commercial journey. Currently, two other drug candidates are in Phase I and II clinical trials in both China and the United States. Frontier Biotechnologies combines expertise from various fields, including research and development, management, and marketing, to establish itself as a competitive player in the global market for long-acting HIV treatments and immunotherapy.

GENESKY

Series A in 2015
Genesky Technology (Suzhou) Co., Ltd. is a private company engaged in gene analysis technology development and application. The firm was founded in 2008 and is based in China.

Virogin Biotech

Seed Round in 2015
Virogin Biotech Ltd., founded in 2015 and based in Vancouver, Canada, focuses on developing innovative oncolytic virus therapeutics aimed at treating cancer. Utilizing its proprietary Synerlytic™ technical platform, the company enhances cancer treatment by harnessing immunological principles to create therapies that stimulate and amplify the body's immune response against tumors. Virogin's approach is centered on leveraging multiple payload expressions to generate a robust and transient antiviral immune response, thereby improving systemic antitumor immunity. With its commitment to advancing immunotherapy, Virogin aims to establish itself as a leader in the field of immuno-oncology.

Youngsen Biotech

Series A in 2014
Developer and Provider of medical devices focused on biotechnology. The company's artificial blood vessels with self-developed polyurethane composite material optimizes the biocompatibility and long-term patency of artificial blood vessels.

Shenogen Pharma Group

Series C in 2013
Shenogen Pharma Group is a drug discovery and development company.

MicroPoint Bioscience

Angel Round in 2009
MicroPoint Bioscience, Inc. (微点生物) is a Chinese company dedicated to biochip research and development. The company offers a product series, Lab On a Chip, which is based on micro-electronic mechanical technologies. MicroPoint Biosciences customizes demanded products and services for customers in areas of human health such as medicine, environmental protection, food safety, scientific research, and other application areas. In the area of medicine, MicroPoint Company's bedside immediate diagnosis chip and examination instrument provides low-cost resolutions for early diagnosis and the process monitoring of vascular diseases, tumors, emergency treatments, and operations.

Guojia New Materials

Series A in 2009
Zhuhai Guojia New Macromolecule Material Co., Ltd. is the first domestic enterprise which professionally engages in the production and sales of gel core material and applied gel core products. The gel technology of the company covers many fields, such as agriculture and forestry, environmental protection, medicine, daily chemicals, and so on. And it owns core technologies and intellectual properties in every field, which have a broad range of applications, good market prospects, and great scientific and technological contentssupport. It is a national-level high-tech enterprise that assembles several high quality resources, such as Wuhan University, China University of Geosciences, the Institute of Chemistry of the Chinese Academy of Sciences, Shenzhen Capital Group Co., Ltd. and so on. The main business of Guojia New Materials is the research, production and sales of core materials of gel, medical gel, applied core products of environment-friendly gel and service for environmental protection technology of heavy metal and sludge.
Beijing Easpring Material Technology Co., Ltd. specializes in the research, development, production, and sale of energy materials, primarily focusing on cathode materials for lithium-ion batteries. Established in 2001 and headquartered in Beijing, the company offers a range of products including NCM532, NCM622, lithium cobalt oxide, and various precursor materials. These materials cater to sectors such as electric vehicles, consumer electronics, and energy storage systems. Easpring has established itself as a key supplier of lithium battery materials in China and has maintained a strong growth trajectory in the industry. In 2010, it became a publicly listed company, marking its position as a significant player in the production of lithium battery anode materials.

3Nod

Series A in 2007
Three Nod Group is a Chinese company that designs, manufactures, and supplies electronic equipment, specializing in audio speaker systems, electronic devices, and computer peripherals. Committed to enhancing the quality of life through scientific and technological innovations, the company advocates for "Intelligent Life" and has developed a deep understanding of user experiences. Through its focus on improving everyday interactions with technology, Three Nod Group aims to create products that resonate with users' needs and preferences.
Xi'an Haotian Biological Engineering technology Co., Ltd (西安皓天) is a Chinese raw material supplier to the global health industry. Xi'an Haotian is specialized in manufacturing quality and reliable raw materials for many industries including functional food, nutritional supplement, cosmetic, pharmaceutical, and feed. It is one of the main raw material exporters in the health industry in China. The researchers in the firm accounts for 31.8% of total number including five doctors and fifteen masters, who are specialized in the fields of extraction and separation, synthetizing, fermenting, pharmacy, dietetics, and more. Xi'an Haotian was established in February 2003.

Netac

Series B in 2003
Netac Technology Co., Ltd. is a prominent flash memory manufacturer based in Shenzhen, China, founded in 1999. The company specializes in the production and sale of various flash memory products, including USB flash drives, portable hard drives, solid state disks, and memory cards. Known for its innovation, Netac holds the distinction of being the inventor of USB-based flash memory technology and has established itself as a leading supplier in the removable storage sector. The company's focus extends to security and encryption features for its products, enhancing the protection of stored data. Netac operates a wholly-owned production facility for its flash storage products and oversees two subsidiaries, Netac Technology (Hong Kong) Limited and Leapro Technology Co., Ltd., with the latter holding the SD-3C license. The company has achieved significant growth since its listing in the Growth Enterprise Market in 2010, becoming the first listed removable storage supplier in China.
Semiconductor Manufacturing International Corporation (SMIC) is a semiconductor foundry providing integrated circuit (IC) foundry and technology services at 0.35-micron to 40-nanometer. SMIC develops one-stop turnkey services to meet its customers’ needs. In addition to IC manufacturing, SMIC offers a full range of services that includes design services, mask manufacturing, and testing. SMIC provides integrated circuit (IC) foundry and technology services on process nodes from 0.35 micron to 28 nanometer. Headquartered in Shanghai, China, SMIC has an international manufacturing and service base. In China, SMIC has a 300mm wafer fabrication facility (fab) and a 200mm mega-fab in Shanghai; a 300mm mega-fab and a majority-owned 300mm fab for advanced nodes in Beijing; 200mm fabs in Tianjin and Shenzhen; and a majority-owned joint-venture 300mm bumping facility in Jiangyin; additionally, in Italy SMIC has a majority-owned 200mm fab. Headquartered in Shanghai, China, SMIC has a 300mm wafer fabrication facility (fab) and a 200mm mega-fab in Shanghai, a 300mm mega-fab in Beijing, a 200mm fab in Tianjin, and a 200mm fab project under development in Shenzhen. SMIC also has customer service and marketing offices in the U.S., Europe, Japan, and Taiwan, and a representative office in Hong Kong. SMIC competes with Taiwan Semiconductor Manufacturing Company, Ltd., United Microelectronics Corporation, GlobalFoundries, Fujitsu Limited, Samsung Electronics Co., Ltd., and Toshiba Corporation.

Netac

Series A in 2002
Netac Technology Co., Ltd. is a prominent flash memory manufacturer based in Shenzhen, China, founded in 1999. The company specializes in the production and sale of various flash memory products, including USB flash drives, portable hard drives, solid state disks, and memory cards. Known for its innovation, Netac holds the distinction of being the inventor of USB-based flash memory technology and has established itself as a leading supplier in the removable storage sector. The company's focus extends to security and encryption features for its products, enhancing the protection of stored data. Netac operates a wholly-owned production facility for its flash storage products and oversees two subsidiaries, Netac Technology (Hong Kong) Limited and Leapro Technology Co., Ltd., with the latter holding the SD-3C license. The company has achieved significant growth since its listing in the Growth Enterprise Market in 2010, becoming the first listed removable storage supplier in China.

MicroPort Scientific

Series C in 2002
Shanghai MicroPort Medical (Group) Co., Ltd., founded in 1998 and based in Shanghai, China, specializes in the development, manufacture, and distribution of cardiovascular and interventional medical devices. The company focuses on minimally invasive products for treating vascular diseases, including its flagship cobalt-chromium alloy drug-eluting stent. In addition to cardiovascular devices, MicroPort offers a range of vascular stent-grafts and specialized stents designed for various surgical applications, including those targeting brain vasculature. Its products are utilized in over 1,100 hospitals across China and are exported to more than 20 countries in the Asia Pacific region, South America, and Europe. As a subsidiary of MicroPort Scientific Corporation, Shanghai MicroPort Medical continues to expand its presence in the medical devices sector.

MicroPort Scientific

Series B in 2002
Shanghai MicroPort Medical (Group) Co., Ltd., founded in 1998 and based in Shanghai, China, specializes in the development, manufacture, and distribution of cardiovascular and interventional medical devices. The company focuses on minimally invasive products for treating vascular diseases, including its flagship cobalt-chromium alloy drug-eluting stent. In addition to cardiovascular devices, MicroPort offers a range of vascular stent-grafts and specialized stents designed for various surgical applications, including those targeting brain vasculature. Its products are utilized in over 1,100 hospitals across China and are exported to more than 20 countries in the Asia Pacific region, South America, and Europe. As a subsidiary of MicroPort Scientific Corporation, Shanghai MicroPort Medical continues to expand its presence in the medical devices sector.
Semiconductor Manufacturing International Corporation (SMIC) is a semiconductor foundry providing integrated circuit (IC) foundry and technology services at 0.35-micron to 40-nanometer. SMIC develops one-stop turnkey services to meet its customers’ needs. In addition to IC manufacturing, SMIC offers a full range of services that includes design services, mask manufacturing, and testing. SMIC provides integrated circuit (IC) foundry and technology services on process nodes from 0.35 micron to 28 nanometer. Headquartered in Shanghai, China, SMIC has an international manufacturing and service base. In China, SMIC has a 300mm wafer fabrication facility (fab) and a 200mm mega-fab in Shanghai; a 300mm mega-fab and a majority-owned 300mm fab for advanced nodes in Beijing; 200mm fabs in Tianjin and Shenzhen; and a majority-owned joint-venture 300mm bumping facility in Jiangyin; additionally, in Italy SMIC has a majority-owned 200mm fab. Headquartered in Shanghai, China, SMIC has a 300mm wafer fabrication facility (fab) and a 200mm mega-fab in Shanghai, a 300mm mega-fab in Beijing, a 200mm fab in Tianjin, and a 200mm fab project under development in Shenzhen. SMIC also has customer service and marketing offices in the U.S., Europe, Japan, and Taiwan, and a representative office in Hong Kong. SMIC competes with Taiwan Semiconductor Manufacturing Company, Ltd., United Microelectronics Corporation, GlobalFoundries, Fujitsu Limited, Samsung Electronics Co., Ltd., and Toshiba Corporation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.